Extension of recall of GlaxoSmithKline's Augmentin (with photo)

The Department of Health today (August 2) ordered GlaxoSmithKline Limited to recall from shelves two more strengths of its Augmentin, namely the 625mg tablet (registration no.: HK-44027) and the 1g tablet (registration no.: HK-42252).